187
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1

, ORCID Icon, , , , , & show all
Pages 579-591 | Received 06 Apr 2023, Accepted 07 Jul 2023, Published online: 24 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.